These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676 [TBL] [Abstract][Full Text] [Related]
3. The use of immunotoxins containing ricin A or B chains to kill neoplastic B cells. Vitetta ES; Uhr JW Ann N Y Acad Sci; 1985; 446():228-36. PubMed ID: 3860153 [No Abstract] [Full Text] [Related]
4. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
5. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Stong RC; Youle RJ; Vallera DA Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879 [TBL] [Abstract][Full Text] [Related]
7. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis. Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic antibodies--delivering the promise? Hale G Adv Drug Deliv Rev; 2006 Aug; 58(5-6):633-9. PubMed ID: 16822575 [TBL] [Abstract][Full Text] [Related]
9. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates. Killen JA; Lindstrom JM J Immunol; 1984 Nov; 133(5):2549-53. PubMed ID: 6332854 [TBL] [Abstract][Full Text] [Related]
10. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Vollmers HP; Brändlein S Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893 [TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin. Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes. Tutt AL; Stevenson FK; Smith JL; Stevenson GT J Immunol; 1983 Dec; 131(6):3058-63. PubMed ID: 6417240 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of experimental animal tumors with antitumor antibodies conjugated to diphtheria toxin or ricin. Moolten F; Zajdel S; Cooperband S Ann N Y Acad Sci; 1976; 277(00):690-9. PubMed ID: 187103 [No Abstract] [Full Text] [Related]
15. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]